Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.41 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 4/20 | 0.38 |
| ▸ | MMP2 | P08253 | 3/20 | 0.38 |
| ▸ | MMP9 | P14780 | 1/20 | 0.38 |
| ▸ | MMP8 | P22894 | 1/20 | 0.38 |
| ▸ | MMP14 | P50281 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 4/20 | 0.37 |
| ▸ | OGG1 | O15527 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | PLCG1 | P19174 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14339307 | 0.94 | ALDH1A1 (0.50) | CYP2A6ALDH1A1MAPK1CES2CES1 | |
| SCHEMBL6568180 | 0.89 | ALDH1A1 (0.52) | CYP2A6ALDH1A1MAPK1CA2LMNA | |
| SCHEMBL2678331 | 0.89 | ALDH1A1 (0.52) | CYP2A6ALDH1A1MAPK1CA2LMNA | |
| SCHEMBL18902368 | 0.87 | ALDH1A1 (0.62) | CYP2A6ALDH1A1LMNATDP1 | |
| SCHEMBL11868638 | 0.87 | ALDH1A1 (0.50) | CYP2A6ALDH1A1MAPK1CA2LMNA | |
| SCHEMBL21309077 | 0.85 | ALDH1A1 (0.61) | ALDH1A1MAPK1CA12CA2CA9 | |
| SCHEMBL23279569 | 0.80 | ALDH1A1 (0.52) | ALDH1A1MAPK1LMNATDP1 | |
| SCHEMBL14422420 | 0.78 | CYP1B1 (0.47) | ALDH1A1MAPK1LMNA | |
| SCHEMBL3361462 | 0.77 | CA2 (0.55) | CYP2A6CES2CES1ALOX15CA12 | |
| SCHEMBL11916201 | 0.77 | CYP2A6 (0.44) | CYP2A6ALDH1A1MAPK1CES2CES1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119968094-A | Hole transport composition, hole transport layer, preparation method of hole transport layer and perovskite battery | 天合光能股份有限公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-116462709-A | Phosphate group-containing compound, preparation method thereof and application thereof in perovskite light-emitting device | 中国科学院长春应用化学研究所 | 2023-07-21 | — | — | CN | disclosed |
| CN-114539301-A | Dendritic fused ring compound containing boron atom and oxygen atom, preparation method and application thereof, and organic electroluminescent device | 中国科学院长春应用化学研究所 | 2022-05-27 | — | — | CN | disclosed |
| EP-1644459-B1 | MIXTURES OF ORGANIC EMISSIVE SEMICONDUCTORS AND MATRIX MATERIALS, AND ELECTRONIC COMPONENTS COMPRISING SAID MIXTURES | MERCK PATENT GMBH (DE) | 2017-08-23 | — | — | EP | disclosed |
| US-9406910-B2 | Organic electroluminescent element and manufacturing method thereof, and phosphorus-containing organic compound and manufacturing method thereof | DAIDEN CO., LTD (JP) | 2016-08-02 | — | — | US | disclosed |
| US-9406910-B2 | Organic electroluminescent element and manufacturing method thereof, and phosphorus-containing organic compound and manufacturing method thereof | DAIDEN CO., LTD (JP) | 2016-08-02 | — | — | US | disclosed |
| US-9206351-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-12-08 | — | — | US | disclosed |
| US-9206351-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-12-08 | — | — | US | disclosed |
| US-9206351-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2015-12-08 | — | — | US | disclosed |
| US-20130295706-A1 | Organic Electroluminescent Element and Manufacturing Method Thereof, and Phosphorus-Containing Organic Compound and Manufacturing Method Thereof | KYUSHU ELECTRIC POWER CO., INC. (JP) | 2013-11-07 | — | — | US | disclosed |
| WO-2007137725-A1 | NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2007-12-06 | — | — | WO | disclosed |
| US-20070185303-A1 | Compounds for organic electronic devices | MERCK PATENT GMBH PATENTS & SCIENTIFIC INFORMATION (DE) | 2007-08-09 | — | — | US | disclosed |
| EP-1250341-B1 | A METHOD OF GENERATING A FUNCTIONALISED ARYLPHOSPHINE | UNIV LIVERPOOL (GB) | 2004-03-31 | — | — | EP | disclosed |
| US-20040059159-A2 | A Method of Generating A Functionalised Arylphosphine | THE UNIVERSITY OF LIVERPOOL (GB) | 2004-03-25 | — | — | US | disclosed |
| US-20030181767-A1 | Method of generating a functionalised arylphosphine | XIAO JIANLIANG (GB) | 2003-09-25 | — | — | US | disclosed |
| EP-1250341-A1 | A METHOD OF GENERATING A FUNCTIONALISED ARYLPHOSPHINE | THE UNIVERSITY OF LIVERPOOL (GB) | 2002-10-23 | — | — | EP | disclosed |
| WO-2001055156-A1 | A METHOD OF GENERATING A FUNCTIONALISED ARYLPHOSPHINE | THE UNIVERSITY OF LIVERPOOL (GB) | 2001-08-02 | — | — | WO | disclosed |
| EP-0011369-B1 | PROCESS FOR PREPARING 3-EXOMETHYLENECEPHAM SULFOXIDES | ELI LILLY AND COMPANY (US) | 1982-03-24 | — | — | EP | disclosed |
| EP-0011369-A1 | Process for preparing 3-exomethylenecepham sulfoxides | ELI LILLY AND COMPANY (US) | 1980-05-28 | — | — | EP | disclosed |
| US-4190724-A | Process for 3-exomethylenecepham sulfoxides | ELI LILLY AND COMPANY (US) | 1980-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030181767-A1 | Method of generating a functionalised arylphosphine | PHOSPHO1, PPIP5K2, PNPO | CYP2A6 688/4885ALDH1A1 2565/4885MAPK1 924/4885 |
| US-20040059159-A2 | A Method of Generating A Functionalised Arylphosphine | PHOSPHO1, PFAS, PPIP5K2 | CYP2A6 914/4885ALDH1A1 2971/4885MAPK1 1233/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.